| HOME >> BIOLOGY >> TECHNOLOGY |
NEW YORK, March 4, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S. and China, announced today that NeoStem will present on a panel at the 31st Annual Cowen Group Health Care Conference. The panel discussion will take place on Monday, March 7, 2011 at 1 PM and Dr. Robin Smith, the Company's Chairman and CEO, will present on Tuesday, March 8, 2011 at 10:15 AM. The Conference will be held at the Boston Marriott Copley Place in Boston, Massachusetts.
The panel will be focused on China which will give NeoStem a platform to discuss its China strategy and highlight recent developments related to China expansion activities. Additionally, the company will discuss why management believes the recent acquisition of Progenitor Cell Therapy, LLC ("PCT") positions the Company to become a leader in cell-based medicine. PCT is an internationally recognized cell therapy services and development company that, through its cGMP certified manufacturing facilities and team of professionals, facilitates the preclinical and clinical development and commercialization of cellular therapies for clients in the United States and internationally. The Company is well positioned to capture the paradigm shift to cell-based medicine.
The Company will discuss future plans such as the launch of a new service by bundling together adult stem cell banking and cord blood banking into a multi-generational stem cell collection and storage plan that the Company will call the "Family Plan" with well-recognized television and online healthcare professional, Dr. Manny Alvarez.
Additionally, the Company will discuss its cell-based therapeutics development strategy in the US and China to articulate near and long term goals and identify where the value inflection points exist.
Dr. Robin Smith said, "It is
'/>"/>
| SOURCE NeoStem, Inc. Copyright©2010 PR Newswire. All rights reserved |